DDInter1168 DDInter1631
Methdilazine is a phenothiazine compound with antihistaminic activity. It is used in the treatment of various dermatoses to relieve pruritus.
Safinamide is for the treatment of parkinson's disease. It was approved in Europe in February 2015, and in the United States on March 21, 2017.
Methdilazine {u} (Compound) resembles {v} (Compound) Thioproperazine
Methdilazine {u} (Compound) resembles {v} (Compound) Epinastine
Methdilazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cyproheptadine
Methdilazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Promethazine
Methdilazine {u} (Compound) binds {v} (Gene) HRH1
Methdilazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magnesium hydroxide
Methdilazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Sucralfate
Methdilazine {u} may lead to a major life threatening interaction when taken with {v} Dextropropoxyphene
Methdilazine {u} may lead to a major life threatening interaction when taken with {v} Deutetrabenazine
Methdilazine {u} (Compound) resembles {v} (Compound) and {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Perphenazine
Methdilazine (Compound) resembles Thioproperazine (Compound)
Methdilazine (Compound) resembles Epinastine (Compound)
Methdilazine may cause a moderate interaction that could exacerbate diseases when taken with Cyproheptadine
Methdilazine may cause a moderate interaction that could exacerbate diseases when taken with Promethazine
Methdilazine (Compound) binds HRH1 (Gene)
Methdilazine may cause a minor interaction that can limit clinical effects when taken with Magnesium hydroxide
Methdilazine may cause a minor interaction that can limit clinical effects when taken with Sucralfate
Methdilazine may lead to a major life threatening interaction when taken with Dextropropoxyphene
Methdilazine may lead to a major life threatening interaction when taken with Deutetrabenazine
Methdilazine (Compound) resembles Perphenazine (Compound) and Methdilazine may cause a moderate interaction that could exacerbate diseases when taken with Perphenazine